Tyrosine Kinase Inhibitor for Treatment of Adult Allogeneic Hematopoietic Stem Cell Transplantation Candidate with Philadelphia-Positive Acute Lymphoblastic Leukemia

被引：0
|
作者：
Wang, Lu [1 ]
Liu, Dai-Hong [1 ]
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing 100082, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2017年 / 130卷 / 02期
关键词：
Acute Lymphoblastic Leukemia; Allogeneic; Transplantation; Tyrosine Kinase Inhibitor; TERM-FOLLOW-UP; CYTOGENETIC RESPONSES; HYPER-CVAD; IMATINIB; CHEMOTHERAPY; DASATINIB; SURVIVAL; PHASE-2;
D O I：
10.4103/0366-6999.197976
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：127 / 129
页数：3
相关论文
共 50 条
  • [1] Tyrosine Kinase Inhibitor for Treatment of Adult Allogeneic Hematopoietic Stem Cell Transplantation Candidate with Philadelphia-Positive Acute Lymphoblastic Leukemia
    Lu Wang
    Dai-Hong Liu
    [J]. 中华医学杂志(英文版), 2017, 130 (02) : 127 - 129
  • [2] Allogeneic hematopoietic cell transplantation for adult Philadelphia-positive acute lymphoblastic leukemia in the era of tyrosine kinase inhibitors
    Abou Mourad, Yasser R.
    Fernandez, Hugo F.
    Kharfan-Dabaja, Mohamed A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (09) : 949 - 958
  • [3] Tyrosine Kinase Inhibitor Treatment after Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
    Chang, Yu-Hsiang
    Liao, Xiu-Wen
    Liu, Jia-Hau
    Yao, Ming
    Ko, Bor-Sheng
    Li, Chi-Cheng
    Tsai, Cheng-Hong
    Wu, Shang-Ju
    Huang, Hui-Hsuan
    Huang, Tai-Chung
    Hou, Hsin-An
    Chou, Wen-Chien
    Tien, Feng-Ming
    Lin, Yun-Chu
    Lu, Meng-Yao
    Lin, Kai-Hsin
    Tang, Jih-Luh
    [J]. BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 201 - 202
  • [4] The impact of tyrosine kinase inhibitors on allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
    Zhang, Yuanfeng
    Feng, Sizhou
    [J]. LEUKEMIA RESEARCH, 2021, 109
  • [5] Tyrosine kinase inhibitors in adult Philadelphia chromosome positive acute lymphoblastic leukemia: before, after, or instead of allogeneic stem cell transplantation
    Lussana, Federico
    Rambaldi, Alessandro
    [J]. DRUGS AND CELL THERAPIES IN HEMATOLOGY, 2016, 4 (01): : 22 - 30
  • [6] Challenges of Maintenance Tyrosine Kinase Inhibitor Therapy after Allogeneic Hematopoietic Cell Transplantation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Othman, Tamer
    Koller, Paul B.
    Tsai, Ni-Chun
    Pourhassan, Hoda
    Agrawal, Vaibhav
    Otoukesh, Salman
    Amanam, Idoroenyi
    Ngo, Dat
    Chen, Jason
    Al Malki, Monzr M.
    Salhotra, Amandeep
    Ali, Haris
    Aribi, Ahmed
    Sandhu, Karamjeet S.
    Arslan, Shukaib
    Ball, Brian J.
    Stewart, Forrest M.
    Curtin, Peter T.
    Artz, Andrew S.
    Snyder, David S.
    Marcucci, Guido
    Forman, Stephen J.
    Stein, Anthony S.
    Nakamura, Ryotaro
    Pullarkat, Vinod A.
    Aldoss, Ibrahim
    Mei, Matthew
    [J]. BLOOD, 2022, 140 : 4821 - 4822
  • [7] Prophylactic or preemptive tyrosine kinase inhibitor therapy after allogeneic hematopoietic cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
    Nakasone, Hideki
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (02) : 183 - 192
  • [8] Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia
    Othman, Tamer
    Koller, Paul
    Tsai, Ni-Chun
    Yang, Dongyun
    Pourhassan, Hoda
    Agrawal, Vaibhav
    Ngo, Dat
    Chen, Jason
    Farol, Leonardo
    Spielberger, Ricardo
    Sahebi, Firoozeh
    Al Malki, Monzr M.
    Cai, Ji-Lian
    Sandhu, Karamjeet S.
    Mansour, Joshua
    Salhotra, Amandeep
    Ali, Haris
    Aribi, Ahmed
    Arslan, Shukaib
    Marcucci, Guido
    Forman, Stephen J.
    Stein, Anthony S.
    Nakamura, Ryotaro
    Pullarkat, Vinod
    Aldoss, Ibrahim
    Mei, Matthew
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (09) : 1680 - 1690
  • [9] Toxicities Associated with Tyrosine Kinase Inhibitor Maintenance Following Allogeneic Hematopoietic Cell Transplantation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Othman, Tamer
    Koller, Paul B.
    Tsai, Ni-Chun
    Ngo, Dat
    Chen, Jason
    Blackmon, Amanda
    Pourhassan, Hoda
    Agrawal, Vaibhav
    Amanam, Idoroenyi
    Ball, Brian J.
    Otoukesh, Salman
    Salhotra, Amandeep
    Arslan, Shukaib
    Al Malki, Monzr M.
    Ali, Haris
    Sandhu, Karamjeet S.
    Aribi, Ahmed
    Artz, Andrew
    Stewart, Forest Marc
    Smith, Eileen Patricia
    Stein, Anthony
    Marcucci, Guido
    Nakamura, Ryotaro
    Pullarkat, Vinod
    Aldoss, Ibrahim
    Mei, Matthew Genyeh
    [J]. BLOOD, 2023, 142
  • [10] Prophylactic or preemptive tyrosine kinase inhibitor therapy after allogeneic hematopoietic cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
    Hideki Nakasone
    [J]. International Journal of Hematology, 2023, 118 : 183 - 192
12345